Palumbo 2015 R-ISS for multiple myeloma. ISS from beta-2 microglobulin and albumin (Greipp 2005). R-ISS I: ISS I, standard-risk iFISH CA, and normal LDH. R-ISS III: ISS III plus high-risk CA (del(17p) and/or t(4;14) and/or t(14;16)) or LDH > ULN. R-ISS II: all other combinations. Not a myeloma diagnosis or treatment choice; not R2-ISS; not Durie-Salmon. magent does not assay beta-2 microglobulin, albumin, LDH, or cytogenetics.
| Network | Scheme | Amount | Pay To |
|---|---|---|---|
| Base | exact | $0.005000 USDC | 0x836B...9Ee2 |